According to a recent LinkedIn post from Okami Medical, a multicenter retrospective study has examined the LOBO embolization device versus traditional coils in proximal splenic embolization. The post highlights that procedures using LOBO reportedly required one device per case in a 22‑patient cohort, while coil-based procedures used between 1 and 19 devices, averaging 4.6 in a similarly sized group.
The company’s LinkedIn post suggests that using a single device per vessel may lead to fewer procedural variables and more predictable outcomes for interventional radiologists. For investors, this positioning could indicate a potential cost-efficiency and workflow advantage in embolization procedures, which may support broader clinical adoption and strengthen Okami Medical’s competitive stance in the interventional radiology and medical device markets, subject to further clinical experience and evidence.